| BBB pathophysiology–independent delivery of siRNA in traumatic brain injury W Li, J Qiu, XL Li, S Aday, J Zhang, G Conley, J Xu, J Joseph, H Lan, ... Science Advances 7 (1), eabd6889, 2021 | 146 | 2021 |
| Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines J Park, J Park, Y Pei, J Xu, Y Yeo Advanced drug delivery reviews 104, 93-109, 2016 | 107 | 2016 |
| A therapeutic convection–enhanced macroencapsulation device for enhancing β cell viability and insulin secretion K Yang, ED O’Cearbhaill, SS Liu, A Zhou, GD Chitnis, AE Hamilos, J Xu, ... Proceedings of the National Academy of Sciences 118 (37), e2101258118, 2021 | 52 | 2021 |
| Recent progress of potentiating immune checkpoint blockade with external stimuli—an industry perspective J Xu, R Saklatvala, S Mittal, S Deshmukh, A Procopio Advanced Science 7 (8), 1903394, 2020 | 41 | 2020 |
| Quinic acid‐conjugated nanoparticles enhance drug delivery to solid tumors via interactions with endothelial selectins J Xu, SSY Lee, H Seo, L Pang, Y Jun, RY Zhang, ZY Zhang, P Kim, W Lee, ... Small 14 (50), 1803601, 2018 | 34 | 2018 |
| A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of β cells K Yang, M Lee, PA Jones, SS Liu, A Zhou, J Xu, V Sreekanth, JLY Wu, ... Science Advances 6 (47), eabc3207, 2020 | 25 | 2020 |
| Development of surface-variable polymeric nanoparticles for drug delivery to tumors N Han, L Pang, J Xu, H Hyun, J Park, Y Yeo Molecular pharmaceutics 14 (5), 1538-1547, 2017 | 24 | 2017 |
| Carfilzomib delivery by quinic acid-conjugated nanoparticles: discrepancy between tumoral drug accumulation and anticancer efficacy in a murine 4T1 orthotopic breast cancer model Y Jun, J Xu, H Kim, JE Park, YS Jeong, JS Min, N Yoon, JY Choi, J Yoo, ... Journal of pharmaceutical sciences 109 (4), 1615-1622, 2020 | 5 | 2020 |
| Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression J Xu, N Solban, Y Wang, H Ferguson, S Perera, K Lin, M Cai, EG Schutt, ... Advanced Therapeutics 4 (10), 2100154, 2021 | 4 | 2021 |
| Development of a 3D printed perfusable in vitro blood–brain barrier model for use as a scalable screening tool MK Royse, M Fowler, AK Mai, Y He, MR Durante, N Buist, A Procopio, ... Biomaterials Science 12 (17), 4363-4375, 2024 | 3 | 2024 |
| A 3D printable perfused hydrogel vascular model to assay ultrasound-induced permeability MK Royse, AK Means, GA Calderon, IS Kinstlinger, Y He, MR Durante, ... Biomaterials Science 10 (12), 3158-3173, 2022 | 3 | 2022 |
| Predicting the long-term stability of biologics with short-term data M Dillon, J Xu, G Thiagarajan, D Skomski, A Procopio Molecular Pharmaceutics 21 (9), 4673-4687, 2024 | 2 | 2024 |
| Quinic acid-modified nanoparticles and uses thereof Y Yeo, J Xu US Patent 11,154,514, 2021 | | 2021 |
